{{Rsnum
|rsid=7556371
|Gene=PIK3C2B
|Chromosome=1
|position=204488208
|Orientation=plus
|GMAF=0.3737
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PIK3C2B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 48.7 | 40.7 | 10.6
| HCB | 51.8 | 40.9 | 7.3
| JPT | 53.1 | 41.6 | 5.3
| YRI | 15.6 | 42.2 | 42.2
| ASW | 15.8 | 36.8 | 47.4
| CHB | 51.8 | 40.9 | 7.3
| CHD | 49.5 | 42.2 | 8.3
| GIH | 44.6 | 51.5 | 4.0
| LWK | 11.8 | 39.1 | 49.1
| MEX | 36.2 | 48.3 | 15.5
| MKK | 16.7 | 44.9 | 38.5
| TSI | 51.0 | 38.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20197460
|Title=Pooled Analysis of Phosphatidylinositol 3-Kinase Pathway Variants and Risk of Prostate Cancer
|OA=1
}}

{{PMID Auto
|PMID=21373201
|Title=Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}